{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:40Z","timestamp":1707524500547},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,28]]},"DOI":"10.7759\/cureus.23556","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T08:01:11Z","timestamp":1648454471000},"source":"Crossref","is-referenced-by-count":1,"title":["Plasma Interleukin-33 Cannot Predict Hip Osteonecrosis in Patients With Sickle Cell Disease: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Alok  C","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachita","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra Kuber","family":"Bodhey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshal","family":"Sakale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit Kumar","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5413.143911","article-title":"Management of femoral head osteonecrosis: current concepts","volume":"49","author":"Tripathy SK","year":"2015","unstructured":"Tripathy SK, Goyal T, Sen RK. Management of femoral head osteonecrosis: current concepts. Indian J Orthop. 2015, 49:28-45. 10.4103\/0019-5413.143911","journal-title":"Indian J Orthop"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1053\/sarh.2002.33724b","article-title":"Pathogenesis and natural history of osteonecrosis","volume":"32","author":"Assouline-Dayan Y","year":"2002","unstructured":"Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002, 32:94-124.","journal-title":"Semin Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017005256","article-title":"Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California","volume":"1","author":"Adesina O","year":"2017","unstructured":"Adesina O, Brunson A, Keegan TH, Wun T. Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California. Blood Adv. 2017, 1:1287-95. 10.1182\/bloodadvances.2017005256","journal-title":"Blood Adv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/21690707.2016.1248273","article-title":"Understanding the roles of intrinsic disorder in subunits of hemoglobin and the disease process of sickle cell anemia","volume":"4","author":"Fitzsimmons R","year":"2016","unstructured":"Fitzsimmons R, Amin N, Uversky VN. Understanding the roles of intrinsic disorder in subunits of hemoglobin and the disease process of sickle cell anemia. Intrinsically Disord Proteins. 2016, 4:e1248273. 10.1080\/21690707.2016.1248273","journal-title":"Intrinsically Disord Proteins"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.74B3.1587879","article-title":"Hip arthroplasty in patients with sickle-cell haemoglobinopathy","volume":"74","author":"Acurio MT","year":"1992","unstructured":"Acurio MT, Friedman RJ. Hip arthroplasty in patients with sickle-cell haemoglobinopathy. J Bone Joint Surg Br. 1992, 74:367-71. 10.1302\/0301-620X.74B3.1587879","journal-title":"J Bone Joint Surg Br"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4172\/1747-0862.1000155","article-title":"Incidence of thalassemia and sickle cell disease in Chhattisgarh, Central India: using Hardy-Weinberg equations","volume":"9","author":"Thakur S","year":"2014","unstructured":"Thakur S, Sharma R, Sharada RN. Incidence of thalassemia and sickle cell disease in Chhattisgarh, Central India: using Hardy-Weinberg equations. J Mol Genet Med. 2014, 9:10.4172\/1747-0862.1000155","journal-title":"J Mol Genet Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5581\/1516-8484.20120036","article-title":"Osteoarticular involvement in sickle cell disease","volume":"34","author":"da Silva Junior GB","year":"2012","unstructured":"da Silva Junior GB, Daher Ede F, da Rocha FA. Osteoarticular involvement in sickle cell disease. Rev Bras Hematol Hemoter. 2012, 34:156-64. 10.5581\/1516-8484.20120036","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.J.00919","article-title":"The natural progression of symptomatic humeral head osteonecrosis in adults with sickle cell disease","volume":"94","author":"Poignard A","year":"2012","unstructured":"Poignard A, Flouzat-Lachaniette CH, Amzallag J, Galacteros F, Hernigou P. The natural progression of symptomatic humeral head osteonecrosis in adults with sickle cell disease. J Bone Joint Surg Am. 2012, 94:156-62. 10.2106\/JBJS.J.00919","journal-title":"J Bone Joint Surg Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2174\/1874325000903010032","article-title":"Multifocal joint osteonecrosis in sickle cell disease","volume":"3","author":"Flouzat-Lachaniete CH","year":"2009","unstructured":"Flouzat-Lachaniete CH, Roussignol X, Poignard A, Mukasa MM, Manicom O, Hernigou P. Multifocal joint osteonecrosis in sickle cell disease. Open Orthop J. 2009, 3:32-5. 10.2174\/1874325000903010032","journal-title":"Open Orthop J"},{"key":"ref10","article-title":"Imaging of avascular necrosis of femoral head: familiar methods and newer trends","volume":"35","author":"Stoica Z","year":"2009","unstructured":"Stoica Z, Dumitrescu D, Popescu M, Gheonea I, Gabor M, BO N. Imaging of avascular necrosis of femoral head: familiar methods and newer trends. Curr Health Sci J. 2009, 35:23-8.","journal-title":"Curr Health Sci J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo","volume":"104","author":"Carriere V","year":"2007","unstructured":"Carriere V, Roussel L, Ortega N, et al.. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A. 2007, 104:282-7. 10.1073\/pnas.0606854104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2010.11.021","article-title":"IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling","volume":"53","author":"Saidi S","year":"2011","unstructured":"Saidi S, Bouri F, Lencel P, et al.. IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling. Cytokine. 2011, 53:347-54. 10.1016\/j.cyto.2010.11.021","journal-title":"Cytokine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.269","article-title":"Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells","volume":"26","author":"Schulze J","year":"2011","unstructured":"Schulze J, Bickert T, Beil FT, et al.. Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells. J Bone Miner Res. 2011, 26:704-17. 10.1002\/jbmr.269","journal-title":"J Bone Miner Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-1268","article-title":"Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro","volume":"152","author":"Saleh H","year":"2011","unstructured":"Saleh H, Eeles D, Hodge JM, et al.. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro. Endocrinology. 2011, 152:1911-22. 10.1210\/en.2010-1268","journal-title":"Endocrinology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03221.x","article-title":"Expression and regulation of interleukin-33 in human monocytes","volume":"130","author":"Nile CJ","year":"2010","unstructured":"Nile CJ, Barksby E, Jitprasertwong P, Preshaw PM, Taylor JJ. Expression and regulation of interleukin-33 in human monocytes. Immunology. 2010, 130:172-80. 10.1111\/j.1365-2567.2009.03221.x","journal-title":"Immunology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar R","year":"2008","unstructured":"Kakkar R, Lee RT. The IL-33\/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov. 2008, 7:827-40. 10.1038\/nrd2660","journal-title":"Nat Rev Drug Discov"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.04.013","article-title":"Interleukin-33: a novel player in osteonecrosis of the femoral head?","volume":"78","author":"Saidi S","year":"2011","unstructured":"Saidi S, Magne D. Interleukin-33: a novel player in osteonecrosis of the femoral head?. Joint Bone Spine. 2011, 78:550-4. 10.1016\/j.jbspin.2011.04.013","journal-title":"Joint Bone Spine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2310\/JIM.0000000000000050","article-title":"Plasma interleukin 33 level in patients with osteonecrosis of femoral head: an alarmin for osteonecrosis of the femoral head?","volume":"62","author":"Zheng L","year":"2014","unstructured":"Zheng L, Wang W, Ni J, et al.. Plasma interleukin 33 level in patients with osteonecrosis of femoral head: an alarmin for osteonecrosis of the femoral head?. J Investig Med. 2014, 62:635-7. 10.2310\/JIM.0000000000000050","journal-title":"J Investig Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1732638","article-title":"Hip osteonecrosis is associated with increased plasma IL-33 level","volume":"2017","author":"Ma J","year":"2017","unstructured":"Ma J, Guo W, Li Z, Wang B, Li S, Wang P. Hip osteonecrosis is associated with increased plasma IL-33 level. Mediators Inflamm. 2017, 2017:1732638. 10.1155\/2017\/1732638","journal-title":"Mediators Inflamm"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0253-2352.2012.06.001","article-title":"The classification of osteonecrosis of the femoral head based on the three pillars structure: China-Japan Friendship Hospital (CJFH) classification","volume":"32","author":"Zirong L","year":"2012","unstructured":"Zirong L, Liu Z, Sun W, et al.. The classification of osteonecrosis of the femoral head based on the three pillars structure: China-Japan Friendship Hospital (CJFH) classification. Chinese J Ortho. 2012, 32:515-20. 10.3760\/cma.j.issn.0253-2352.2012.06.001","journal-title":"Chinese J Ortho"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/91464-plasma-interleukin-33-cannot-predict-hip-osteonecrosis-in-patients-with-sickle-cell-disease-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:46Z","timestamp":1707507766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/91464-plasma-interleukin-33-cannot-predict-hip-osteonecrosis-in-patients-with-sickle-cell-disease-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.23556","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,28]]}}}